Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus.

Background: Stress hyperglycemia in the critically ill is associated with increased morbidity and mortality. Continuous glucose monitoring offers a solution to the difficulties of dosing intravenous insulin properly to maintain glycemic control. The purpose of this study was to evaluate an intravascular continuous glucose monitoring (IV-CGM) system with a sensing element based on the concept of quenched fluorescence.

Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus.

Background: This pilot trial was designed to determine if an optimal dose of Technosphere(®) insulin (TI) inhalation powder (MannKind Corp., Valencia, CA) could be used regardless of variation in meal carbohydrate (CHO) content.

Subjects And Methods: In total, eight subjects (seven men, one woman) with type 2 diabetes were enrolled.

Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system.

Background: This article describes two novel and easy approaches for assessing the accuracy of insulin pumps as implemented within the artificial pancreas system. The approaches are illustrated by data testing the OmniPod Insulin Management System at its lowest delivery volume (0.05 U) and at doses of 0.